Collegium Pharmaceutical, Inc.

COLL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$70,565$238,947$173,688$186,426
Short-Term Investments$92,198$71,601$0$0
Receivables$228,540$179,525$183,119$105,844
Inventory$35,560$32,332$46,501$17,394
Other Curr. Assets$55,394$15,195$16,681$5,879
Total Curr. Assets$482,257$537,600$419,989$315,543
Property Plant & Equip (Net)$20,151$22,012$26,382$27,135
Goodwill$162,333$133,857$133,695$0
Intangibles$891,402$421,708$567,468$268,723
Long-Term Investments$0$0$0$0
Tax Assets$98,033$26,259$23,950$78,042
Other NC Assets$9,415$1,872$2,647$2,634
Total NC Assets$1,181,334$605,708$754,142$376,534
Other Assets$0$0$0$0
Total Assets$1,663,591$1,143,308$1,174,131$692,077
Liabilities
Payables$3,934$8,692$3,494$4,189
Short-Term Debt$65,854$184,321$163,612$49,167
Tax Payable$15,185$7,149$4,352$3,192
Deferred Revenue$0$988$0$0
Other Curr. Liab.$424,537$256,765$262,268$223,018
Total Curr. Liab.$509,510$457,915$433,726$279,566
LT Debt$793,444$489,962$545,563$209,583
Deferred Rev, NC$10,000$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$121,795$0$0$0
Total NC Liab.$925,239$489,962$545,563$209,583
Other Liabilities$0$0$0$0
Cap. Leases$6,810$7,112$8,224$8,765
Total Liabilities$1,434,749$947,877$979,289$489,149
Equity
Pref Stock$0$0$0$0
Common Stock$40$38$37$36
Retained Earnings-$163,999-$233,189-$281,344-$256,342
AOCI$55$14$0$0
Other Equity$392,746$428,568$476,149$459,234
Total Equity$228,842$195,431$194,842$202,928
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,663,591$1,143,308$1,174,131$692,077
Net Debt$788,733$435,336$535,487$72,324